The flu shot is different this year, thanks to COVID - NPR
Oct 17, 2024 · This year’s flu shot will be missing a strain of influenza it’s protected against for more than a decade. That’s because there have been no confirmed flu cases caused by the Influenza B ...
Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
Sep 14, 2022 · First Phase 3 efficacy study to be conducted using an mRNA-based influenza vaccine; study will enroll 25,000 U.S. adults 18 years and older; Influenza causes 140,000 to 710,000 hospitalizations and 12,000 to 52,000 deaths in the U.S. every year 1
Moderna says mRNA flu shot generates better immune response in ... - CNN
Sep 13, 2023 · Moderna said Wednesday that its experimental mRNA-based seasonal flu vaccine generated a stronger immune response against four strains of the flu virus than a currently marketed vaccine in a...
CDC finds flu shots 42% effective this season, better than ... - CBS News
Feb 29, 2024 · This season's influenza vaccines have been 42% effective so far, according to a new interim estimate from the Centers for Disease Control and Prevention, amounting to protection against the...
Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine …
Aug 16, 2024 · This release contains forward-looking information about Pfizer’s investigational modified RNA (modRNA) influenza vaccine candidates, potential next-generation mRNA flu and combination vaccine formulations, Pfizer’s and BioNTech’s mRNA-based combination vaccine candidate for influenza and COVID-19, the flu and COVID/flu combination ...
New mRNA Flu Shots Are Coming | TIME
Sep 14, 2022 · Moderna and Pfizer are testing mRNA flu shots that target the strains most likely to circulate during the 2022 flu season.
Multivalent next generation influenza virus vaccines protect …
Jan 16, 2024 · A next-generation influenza virus vaccine would provide long-lasting, broadly-reactive immune protection against current and future influenza virus strains for both seasonal and...
Clinical trial of mRNA universal influenza vaccine candidate begins
May 15, 2023 · A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health, has begun enrolling volunteers at Duke University in Durham, North Carolina.
Researchers make important progress toward a possible universal flu vaccine
Dec 22, 2022 · In a significant step, researchers recently said they’ve been able to immunize animals against all 20 known influenza A and B virus strains, marking an important step toward the goal of a single...
Pfizer and BioNTech Announce Positive Topline Data for mRNA …
Oct 26, 2023 · This release contains forward-looking information about Pfizer’s and BioNTech’s mRNA-based combination vaccine candidate for influenza and COVID-19 among healthy adults 18 to 64 years of age, including its potential benefits, plans to initiate a pivotal Phase 3 trial, Pfizer’s ambition of providing a broad portfolio of respiratory ...